Concepedia

Roberta Montagnoli

RM

3

Publications

46

Citations

3

H-Index

2017

Active since

Affiliations

Novo Nordisk (Italy)(Current)

Novo Nordisk (United Kingdom)

Novo Nordisk (Denmark)

Roberta Montagnoli is an author at Novo Nordisk (Italy) specializing in pharmacotherapy, diabetes, and medicine.

ORCID

Top concepts

Publications per year

2017–2019

3

Publications

3

Long-term Cost-effectiveness of Two GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in the Italian Setting: Liraglutide Versus Lixisenatide

Barnaby Hunt, Nana Kragh, Ceilidh C. McConnachie et al. · Clinical Therapeutics · 2017 · 24 citations

, , +5

The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System

Witesh Parekh, Sophie E. Streeton, James Baker‐Knight et al. · Diabetes Therapy · 2018 · 11 citations · Full text

<p>Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy</p>

Johannes Pöhlmann, Roberta Montagnoli, Giusi Lastoria et al. · ClinicoEconomics and Outcomes Research · 2019 · 11 citations · Full text

Rows per page

1–3 of 3